meRfi®-GM
Gut microbiota & Streptomycin
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Streptomycin shifted the balance between the two dominant phyla in the mouse gut toward a Bacteroidetes-dominated microbiota
It was shown that the minimum infective oral dose of Salmonella enterica subsp. enterica serovar Enteritidis decreased 10,000-fold in mice following streptomycin therapy
…
References (Sources)
- Changes in the mouse's enteric microflora associated with enhanced susceptibility to Salmonella infection following streptomycin treatment
- Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection
- Enhanced susceptibility to Salmonella infection in streptomycin-treated mice
- Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota
- Resistance of the mouse's intestinal tract to experimental Salmonella infection. II. Factors responsible for its loss following streptomycin treatment